Heart Attack

The following video features Barry Coller, the Physician in Chief at the Rockefeller University. His bio says "Dr. Coller established the platelet αIIbβ3 (GPIIb/IIIa) receptor as an important target for antithrombotic therapy. This led him to develop monoclonal antibodies to the αIIbβ3 receptor that inhibit platelet aggregation" but you may find the following (musical) statement less dry.  We put this together as part of the NIH Common Fund video competition and ended up tied for second place out of 57 entries as determined by NIH Director Francis Colllins. 

Log In